This report contains market size and forecasts of Pulmonary Drug Delivery Devices/Systems in global, including the following market information:
Global Pulmonary Drug Delivery Devices/Systems Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global Pulmonary Drug Delivery Devices/Systems Market Sales, 2016-2021, 2022-2027, (K Units)
Global top five Pulmonary Drug Delivery Devices/Systems companies in 2020 (%)
The global Pulmonary Drug Delivery Devices/Systems market was valued at 2877.4 million in 2020 and is projected to reach US$ 3368.7 million by 2027, at a CAGR of 4.0% during the forecast period.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Pulmonary Drug Delivery Devices/Systems manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Pulmonary Drug Delivery Devices/Systems Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (K Units)
Global Pulmonary Drug Delivery Devices/Systems Market Segment Percentages, By Type, 2020 (%)
Metered Dose Inhalers
Dry Powder Inhalers
Nebulizers
Accessories
Global Pulmonary Drug Delivery Devices/Systems Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (K Units)
Global Pulmonary Drug Delivery Devices/Systems Market Segment Percentages, By Application, 2020 (%)
Hospitals and Clinics
Homecare
Global Pulmonary Drug Delivery Devices/Systems Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions) & (K Units)
Global Pulmonary Drug Delivery Devices/Systems Market Segment Percentages, By Region and Country, 2020 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Pulmonary Drug Delivery Devices/Systems revenues in global market, 2016-2021 (Estimated), ($ millions)
Key companies Pulmonary Drug Delivery Devices/Systems revenues share in global market, 2020 (%)
Key companies Pulmonary Drug Delivery Devices/Systems sales in global market, 2016-2021 (Estimated), (K Units)
Key companies Pulmonary Drug Delivery Devices/Systems sales share in global market, 2020 (%)
Further, the report presents profiles of competitors in the market, key players include:
Hovione
3M Health Care
Bespak
BeyonDevices
GlaxoSmithKline
H&T Presspart
PARI Respiratory Equipment
Philips Respironics
SHL
Table of Contents
1 Introduction to Research & Analysis Reports
1.1 Pulmonary Drug Delivery Devices/Systems Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Pulmonary Drug Delivery Devices/Systems Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Pulmonary Drug Delivery Devices/Systems Overall Market Size
2.1 Global Pulmonary Drug Delivery Devices/Systems Market Size: 2021 VS 2027
2.2 Global Pulmonary Drug Delivery Devices/Systems Revenue, Prospects & Forecasts: 2016-2027
2.3 Global Pulmonary Drug Delivery Devices/Systems Sales (Consumption): 2016-2027
3 Company Landscape
3.1 Top Pulmonary Drug Delivery Devices/Systems Players in Global Market
3.2 Top Global Pulmonary Drug Delivery Devices/Systems Companies Ranked by Revenue
3.3 Global Pulmonary Drug Delivery Devices/Systems Revenue by Companies
3.4 Global Pulmonary Drug Delivery Devices/Systems Sales by Companies
3.5 Global Pulmonary Drug Delivery Devices/Systems Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Pulmonary Drug Delivery Devices/Systems Companies in Global Market, by Revenue in 2020
3.7 Global Manufacturers Pulmonary Drug Delivery Devices/Systems Product Type
3.8 Tier 1, Tier 2 and Tier 3 Pulmonary Drug Delivery Devices/Systems Players in Global Market
3.8.1 List of Global Tier 1 Pulmonary Drug Delivery Devices/Systems Companies
3.8.2 List of Global Tier 2 and Tier 3 Pulmonary Drug Delivery Devices/Systems Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Pulmonary Drug Delivery Devices/Systems Market Size Markets, 2021 & 2027
4.1.2 Metered Dose Inhalers
4.1.3 Dry Powder Inhalers
4.1.4 Nebulizers
4.1.5 Accessories
4.2 By Type - Global Pulmonary Drug Delivery Devices/Systems Revenue & Forecasts
4.2.1 By Type - Global Pulmonary Drug Delivery Devices/Systems Revenue, 2016-2021
4.2.2 By Type - Global Pulmonary Drug Delivery Devices/Systems Revenue, 2022-2027
4.2.3 By Type - Global Pulmonary Drug Delivery Devices/Systems Revenue Market Share, 2016-2027
4.3 By Type - Global Pulmonary Drug Delivery Devices/Systems Sales & Forecasts
4.3.1 By Type - Global Pulmonary Drug Delivery Devices/Systems Sales, 2016-2021
4.3.2 By Type - Global Pulmonary Drug Delivery Devices/Systems Sales, 2022-2027
4.3.3 By Type - Global Pulmonary Drug Delivery Devices/Systems Sales Market Share, 2016-2027
4.4 By Type - Global Pulmonary Drug Delivery Devices/Systems Price (Manufacturers Selling Prices), 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Pulmonary Drug Delivery Devices/Systems Market Size, 2021 & 2027
5.1.2 Hospitals and Clinics
5.1.3 Homecare
5.2 By Application - Global Pulmonary Drug Delivery Devices/Systems Revenue & Forecasts
5.2.1 By Application - Global Pulmonary Drug Delivery Devices/Systems Revenue, 2016-2021
5.2.2 By Application - Global Pulmonary Drug Delivery Devices/Systems Revenue, 2022-2027
5.2.3 By Application - Global Pulmonary Drug Delivery Devices/Systems Revenue Market Share, 2016-2027
5.3 By Application - Global Pulmonary Drug Delivery Devices/Systems Sales & Forecasts
5.3.1 By Application - Global Pulmonary Drug Delivery Devices/Systems Sales, 2016-2021
5.3.2 By Application - Global Pulmonary Drug Delivery Devices/Systems Sales, 2022-2027
5.3.3 By Application - Global Pulmonary Drug Delivery Devices/Systems Sales Market Share, 2016-2027
5.4 By Application - Global Pulmonary Drug Delivery Devices/Systems Price (Manufacturers Selling Prices), 2016-2027
6 Sights by Region
6.1 By Region - Global Pulmonary Drug Delivery Devices/Systems Market Size, 2021 & 2027
6.2 By Region - Global Pulmonary Drug Delivery Devices/Systems Revenue & Forecasts
6.2.1 By Region - Global Pulmonary Drug Delivery Devices/Systems Revenue, 2016-2021
6.2.2 By Region - Global Pulmonary Drug Delivery Devices/Systems Revenue, 2022-2027
6.2.3 By Region - Global Pulmonary Drug Delivery Devices/Systems Revenue Market Share, 2016-2027
6.3 By Region - Global Pulmonary Drug Delivery Devices/Systems Sales & Forecasts
6.3.1 By Region - Global Pulmonary Drug Delivery Devices/Systems Sales, 2016-2021
6.3.2 By Region - Global Pulmonary Drug Delivery Devices/Systems Sales, 2022-2027
6.3.3 By Region - Global Pulmonary Drug Delivery Devices/Systems Sales Market Share, 2016-2027
6.4 North America
6.4.1 By Country - North America Pulmonary Drug Delivery Devices/Systems Revenue, 2016-2027
6.4.2 By Country - North America Pulmonary Drug Delivery Devices/Systems Sales, 2016-2027
6.4.3 US Pulmonary Drug Delivery Devices/Systems Market Size, 2016-2027
6.4.4 Canada Pulmonary Drug Delivery Devices/Systems Market Size, 2016-2027
6.4.5 Mexico Pulmonary Drug Delivery Devices/Systems Market Size, 2016-2027
6.5 Europe
6.5.1 By Country - Europe Pulmonary Drug Delivery Devices/Systems Revenue, 2016-2027
6.5.2 By Country - Europe Pulmonary Drug Delivery Devices/Systems Sales, 2016-2027
6.5.3 Germany Pulmonary Drug Delivery Devices/Systems Market Size, 2016-2027
6.5.4 France Pulmonary Drug Delivery Devices/Systems Market Size, 2016-2027
6.5.5 U.K. Pulmonary Drug Delivery Devices/Systems Market Size, 2016-2027
6.5.6 Italy Pulmonary Drug Delivery Devices/Systems Market Size, 2016-2027
6.5.7 Russia Pulmonary Drug Delivery Devices/Systems Market Size, 2016-2027
6.5.8 Nordic Countries Pulmonary Drug Delivery Devices/Systems Market Size, 2016-2027
6.5.9 Benelux Pulmonary Drug Delivery Devices/Systems Market Size, 2016-2027
6.6 Asia
6.6.1 By Region - Asia Pulmonary Drug Delivery Devices/Systems Revenue, 2016-2027
6.6.2 By Region - Asia Pulmonary Drug Delivery Devices/Systems Sales, 2016-2027
6.6.3 China Pulmonary Drug Delivery Devices/Systems Market Size, 2016-2027
6.6.4 Japan Pulmonary Drug Delivery Devices/Systems Market Size, 2016-2027
6.6.5 South Korea Pulmonary Drug Delivery Devices/Systems Market Size, 2016-2027
6.6.6 Southeast Asia Pulmonary Drug Delivery Devices/Systems Market Size, 2016-2027
6.6.7 India Pulmonary Drug Delivery Devices/Systems Market Size, 2016-2027
6.7 South America
6.7.1 By Country - South America Pulmonary Drug Delivery Devices/Systems Revenue, 2016-2027
6.7.2 By Country - South America Pulmonary Drug Delivery Devices/Systems Sales, 2016-2027
6.7.3 Brazil Pulmonary Drug Delivery Devices/Systems Market Size, 2016-2027
6.7.4 Argentina Pulmonary Drug Delivery Devices/Systems Market Size, 2016-2027
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Pulmonary Drug Delivery Devices/Systems Revenue, 2016-2027
6.8.2 By Country - Middle East & Africa Pulmonary Drug Delivery Devices/Systems Sales, 2016-2027
6.8.3 Turkey Pulmonary Drug Delivery Devices/Systems Market Size, 2016-2027
6.8.4 Israel Pulmonary Drug Delivery Devices/Systems Market Size, 2016-2027
6.8.5 Saudi Arabia Pulmonary Drug Delivery Devices/Systems Market Size, 2016-2027
6.8.6 UAE Pulmonary Drug Delivery Devices/Systems Market Size, 2016-2027
7 Manufacturers & Brands Profiles
7.1 Hovione
7.1.1 Hovione Corporate Summary
7.1.2 Hovione Business Overview
7.1.3 Hovione Pulmonary Drug Delivery Devices/Systems Major Product Offerings
7.1.4 Hovione Pulmonary Drug Delivery Devices/Systems Sales and Revenue in Global (2016-2021)
7.1.5 Hovione Key News
7.2 3M Health Care
7.2.1 3M Health Care Corporate Summary
7.2.2 3M Health Care Business Overview
7.2.3 3M Health Care Pulmonary Drug Delivery Devices/Systems Major Product Offerings
7.2.4 3M Health Care Pulmonary Drug Delivery Devices/Systems Sales and Revenue in Global (2016-2021)
7.2.5 3M Health Care Key News
7.3 Bespak
7.3.1 Bespak Corporate Summary
7.3.2 Bespak Business Overview
7.3.3 Bespak Pulmonary Drug Delivery Devices/Systems Major Product Offerings
7.3.4 Bespak Pulmonary Drug Delivery Devices/Systems Sales and Revenue in Global (2016-2021)
7.3.5 Bespak Key News
7.4 BeyonDevices
7.4.1 BeyonDevices Corporate Summary
7.4.2 BeyonDevices Business Overview
7.4.3 BeyonDevices Pulmonary Drug Delivery Devices/Systems Major Product Offerings
7.4.4 BeyonDevices Pulmonary Drug Delivery Devices/Systems Sales and Revenue in Global (2016-2021)
7.4.5 BeyonDevices Key News
7.5 GlaxoSmithKline
7.5.1 GlaxoSmithKline Corporate Summary
7.5.2 GlaxoSmithKline Business Overview
7.5.3 GlaxoSmithKline Pulmonary Drug Delivery Devices/Systems Major Product Offerings
7.5.4 GlaxoSmithKline Pulmonary Drug Delivery Devices/Systems Sales and Revenue in Global (2016-2021)
7.5.5 GlaxoSmithKline Key News
7.6 H&T Presspart
7.6.1 H&T Presspart Corporate Summary
7.6.2 H&T Presspart Business Overview
7.6.3 H&T Presspart Pulmonary Drug Delivery Devices/Systems Major Product Offerings
7.6.4 H&T Presspart Pulmonary Drug Delivery Devices/Systems Sales and Revenue in Global (2016-2021)
7.6.5 H&T Presspart Key News
7.7 PARI Respiratory Equipment
7.7.1 PARI Respiratory Equipment Corporate Summary
7.7.2 PARI Respiratory Equipment Business Overview
7.7.3 PARI Respiratory Equipment Pulmonary Drug Delivery Devices/Systems Major Product Offerings
7.4.4 PARI Respiratory Equipment Pulmonary Drug Delivery Devices/Systems Sales and Revenue in Global (2016-2021)
7.7.5 PARI Respiratory Equipment Key News
7.8 Philips Respironics
7.8.1 Philips Respironics Corporate Summary
7.8.2 Philips Respironics Business Overview
7.8.3 Philips Respironics Pulmonary Drug Delivery Devices/Systems Major Product Offerings
7.8.4 Philips Respironics Pulmonary Drug Delivery Devices/Systems Sales and Revenue in Global (2016-2021)
7.8.5 Philips Respironics Key News
7.9 SHL
7.9.1 SHL Corporate Summary
7.9.2 SHL Business Overview
7.9.3 SHL Pulmonary Drug Delivery Devices/Systems Major Product Offerings
7.9.4 SHL Pulmonary Drug Delivery Devices/Systems Sales and Revenue in Global (2016-2021)
7.9.5 SHL Key News
8 Global Pulmonary Drug Delivery Devices/Systems Production Capacity, Analysis
8.1 Global Pulmonary Drug Delivery Devices/Systems Production Capacity, 2016-2027
8.2 Pulmonary Drug Delivery Devices/Systems Production Capacity of Key Manufacturers in Global Market
8.3 Global Pulmonary Drug Delivery Devices/Systems Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Pulmonary Drug Delivery Devices/Systems Supply Chain Analysis
10.1 Pulmonary Drug Delivery Devices/Systems Industry Value Chain
10.2 Pulmonary Drug Delivery Devices/Systems Upstream Market
10.3 Pulmonary Drug Delivery Devices/Systems Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Pulmonary Drug Delivery Devices/Systems Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
List of Tables
Table 1. Key Players of Pulmonary Drug Delivery Devices/Systems in Global Market
Table 2. Top Pulmonary Drug Delivery Devices/Systems Players in Global Market, Ranking by Revenue (2019)
Table 3. Global Pulmonary Drug Delivery Devices/Systems Revenue by Companies, (US$, Mn), 2016-2021
Table 4. Global Pulmonary Drug Delivery Devices/Systems Revenue Share by Companies, 2016-2021
Table 5. Global Pulmonary Drug Delivery Devices/Systems Sales by Companies, (K Units), 2016-2021
Table 6. Global Pulmonary Drug Delivery Devices/Systems Sales Share by Companies, 2016-2021
Table 7. Key Manufacturers Pulmonary Drug Delivery Devices/Systems Price (2016-2021) & (USD/Unit)
Table 8. Global Manufacturers Pulmonary Drug Delivery Devices/Systems Product Type
Table 9. List of Global Tier 1 Pulmonary Drug Delivery Devices/Systems Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Pulmonary Drug Delivery Devices/Systems Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type
Hovione
3M Health Care
Bespak
BeyonDevices
GlaxoSmithKline
H&T Presspart
PARI Respiratory Equipment
Philips Respironics
SHL